These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30770229)

  • 1. MODY 3 diabetes, not every early onset diabetes is type 1 diabetes.
    Sánchez Malo MJ; Arrudi Moreno M; Lou Francés GM
    Endocrinol Diabetes Nutr (Engl Ed); 2019 Apr; 66(4):271-272. PubMed ID: 30770229
    [No Abstract]   [Full Text] [Related]  

  • 2. Onset of type 1 diabetes mellitus in two patients with maturity onset diabetes of the young.
    Maltoni G; Zucchini S; Scipione M; Mantovani V; Salardi S; Cicognani A
    Pediatr Diabetes; 2012 Mar; 13(2):208-12. PubMed ID: 21696527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical parameters for molecular testing of Maturity Onset Diabetes of the Young (MODY)].
    Datz N; Nestoris C; von Schütz W; Danne T; Driesel AJ; Maringa M; Kordonouri O
    Dtsch Med Wochenschr; 2011 May; 136(21):1111-5. PubMed ID: 21590629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young.
    Thanabalasingham G; Pal A; Selwood MP; Dudley C; Fisher K; Bingley PJ; Ellard S; Farmer AJ; McCarthy MI; Owen KR
    Diabetes Care; 2012 Jun; 35(6):1206-12. PubMed ID: 22432108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When to consider a diagnosis of MODY at the presentation of diabetes: aetiology matters for correct management.
    Juszczak A; Pryse R; Schuman A; Owen KR
    Br J Gen Pract; 2016 Jun; 66(647):e457-9. PubMed ID: 27231307
    [No Abstract]   [Full Text] [Related]  

  • 6. HNF1A gene p.I27L is associated with early-onset, maturity-onset diabetes of the young-like diabetes in Turkey.
    Beysel S; Eyerci N; Pinarli FA; Kizilgul M; Ozcelik O; Caliskan M; Cakal E
    BMC Endocr Disord; 2019 May; 19(1):51. PubMed ID: 31109344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes.
    Besser RE; Shepherd MH; McDonald TJ; Shields BM; Knight BA; Ellard S; Hattersley AT
    Diabetes Care; 2011 Feb; 34(2):286-91. PubMed ID: 21270186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of hepatic nuclear factor 1A monogenic diabetes mellitus (HNF1A-MODY) impacts antihyperglycemic treatment.
    Schnedl WJ; Holasek SJ; Schenk M; Enko D; Mangge H
    Wien Klin Wochenschr; 2021 Mar; 133(5-6):241-244. PubMed ID: 33245425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful maintenance on sulphonylurea therapy and low diabetes complication rates in a HNF1A-MODY cohort.
    Bacon S; Kyithar MP; Rizvi SR; Donnelly E; McCarthy A; Burke M; Colclough K; Ellard S; Byrne MM
    Diabet Med; 2016 Jul; 33(7):976-84. PubMed ID: 26479152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes.
    Shields BM; McDonald TJ; Ellard S; Campbell MJ; Hyde C; Hattersley AT
    Diabetologia; 2012 May; 55(5):1265-72. PubMed ID: 22218698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of type-1 diabetes mellitus formerly diagnosed as maturity-onset diabetes of the young (MODY) carrying suggestive MODY3 gene.
    Miura J; Sanaka M; Ikeda Y; Watanabe C; Nakagami T; Iwasaki N; Uchigata Y; Takahashi C; Omori Y; Iwamoto Y
    Diabetes Res Clin Pract; 1997 Nov; 38(2):139-41. PubMed ID: 9483378
    [No Abstract]   [Full Text] [Related]  

  • 12. RD Lawrence lecture 2012: assessing aetiology in diabetes: how C-peptide, CRP and fucosylation came to the party!
    Owen KR
    Diabet Med; 2013 Mar; 30(3):260-6. PubMed ID: 23106207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple diabetes: coexistence of type 1 diabetes mellitus and a novel mutation in the gene responsible for MODY3 in an overweight adolescent.
    Bowden SA; Hoffman RP
    Pediatr Diabetes; 2008 Apr; 9(2):162-4. PubMed ID: 18221440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDL cholesterol as a diagnostic tool for clinical differentiation of GCK-MODY from HNF1A-MODY and type 1 diabetes in children and young adults.
    Fendler W; Borowiec M; Antosik K; Szadkowska A; Deja G; Jarosz-Chobot P; Mysliwiec M; Wyka K; Pietrzak I; Skupien J; Malecki MT; Mlynarski W
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):321-7. PubMed ID: 21521320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis in diabetes: does it matter?
    Thethy I; Robertson L; Swaminathan K
    J R Coll Physicians Edinb; 2011 Jun; 41(2):119-21. PubMed ID: 21677915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical heterogeneity of childhood diabetes in Baranya county].
    Makovi H; Soltész G; Hermann R
    Orv Hetil; 2002 Nov; 143(44):2489-92. PubMed ID: 12674804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maturity-onset diabetes of the young (MODY) mutation in type 2 diabetes and latent autoimmune diabetes of the adult.
    McKinney J; Cao H; Behme MT; Mahon JL; Hegele RA
    Diabetes Care; 2003 Dec; 26(12):3358-9. PubMed ID: 14633836
    [No Abstract]   [Full Text] [Related]  

  • 18. Response to oral gliclazide in a pre-pubertal child with hepatic nuclear factor-1 alpha maturity onset diabetes of the young.
    Habeb AM; George ET; Mathew V; Hattersley AL
    Ann Saudi Med; 2011; 31(2):190-3. PubMed ID: 21242637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and molecular characterization of maturity onset-diabetes of the young caused by hepatocyte nuclear factor-4 alpha mutation: red flags for prediction of the diagnosis.
    Mohamed S; Elkholy S; El-Meleagy E; Abu-Amero K; Hellani AM
    Ann Saudi Med; 2014; 34(3):217-21. PubMed ID: 25266181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-Based Assessment of a Biomarker-Based Screening Pathway to Aid Diagnosis of Monogenic Diabetes in Young-Onset Patients.
    Shields BM; Shepherd M; Hudson M; McDonald TJ; Colclough K; Peters J; Knight B; Hyde C; Ellard S; Pearson ER; Hattersley AT;
    Diabetes Care; 2017 Aug; 40(8):1017-1025. PubMed ID: 28701371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.